We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Faulty Immune-Boosting Cells Initiate Autoimmunity

By Biotechdaily staff writers
Posted on 13 Mar 2006
The failure of programming that triggers the death of dendritic cells, those that activate the immune system, can initiate autoimmune disease, according to researchers in a recent report that appears in the February 24, 2006, issue of the journal Science. More...

The problem begins with a process called programmed cell death, or apoptosis, according to Dr. Jin Wang, assistant professor of immunology at Baylor College of Medicine (Houston, TX, USA). Mice engineered to have a defect in apoptosis of their dendritic cells went on to develop autoimmune disease, Dr. Wang said. "This suggests that defective apoptosis of dendritic cells can be a critical component of autoimmune diseases.”

Autoimmune diseases, such as lupus and juvenile diabetes, occur when the immune system begins attacking the body's own tissues instead of foreign organisms. "We knew that autoimmunity in general can be caused when dendritic cells are unchecked, either by programmed cell death or overactivation,” said Dr. Wang. "Dendritic cells are the initiators of immunity.” They do this by showing or presenting foreign antigens from invading bacteria or viruses to the immune system, which then triggers lymphocytes to attack.

Before this, many scientists believed autoimmunity occurred through apoptosis because of accumulating lymphocytes or white blood cells--major components of the immune system. "If they didn't die, we thought they would start to accumulate and do damage to the body's own tissues,” Dr. Wang stated. However, at least eight studies that suppressed programmed cell death in lymphocytes did not induce autoimmune disease in animals.

In the future, Dr. Wang and his colleagues plan to fill in the gaps between what occurs when apoptosis is hindered in the dendritic cells and the occurrence of autoimmune disease.



Related Links:
Baylor College of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Urine Analyzer
respons® UDS100
New
Slide Scanner System
NanoZoomer S540MD
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.